Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sidra Medicine | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary goal of the study is to identify biomarkers from the molecular signature predictive of pre-term birth. This will be achieved through high frequency sampling and profiling throughout pregnancy.
BACKGROUND Preterm birth occurs before 37 weeks and is a major cause of neonatal mortality and morbidity, and affecting 8% of newborns on the Thailand-Myanmar border. Identifying biochemical markers that are associated with preterm birth can guide in designing the most effective targeted intervention strategies for women at risk.
In order to identify biomarkers signatures predictive of preterm birth the investigators will employ high throughput profiling technologies (aka "a systems approach") that maximize the amount of information that can be obtained and knowledge generated from each participant sample. Preliminary data will also be obtained for infectious complications in order to assess potential for a systems approach such approach in detecting infectious events before onset of clinical symptoms or in absence of clinical symptoms. The rationale behind such approach and its importance for establishing personalized medicine approaches was detailed in a recent opinion article published. In addition parallel studies will be carried out in other countries such as Qatar and the US in order to assess environmental influences on blood and transcriptome signatures.
RESEARCH DESIGN This is a prospective pregnancy cohort from the first trimester until post-partum. The investigators are unable to predict which women will have preterm birth or infection.
STUDY POPULATION 400 Pregnant women with confirmed viable pregnancy of more than 8+0 weeks and less than 14 weeks of pregnancy, who are healthy, intend to deliver at SMRU and can attend for two weekly ANC visits.
METHOD AND TECHNIQUE
Pregnant women attending SMRU ANC clinics will be invited to participate in the study.
Study samples will include:
The post-partum visits, will be at 4-6 weeks and at 3months. The investigators estimate 15-18 blood samples, and 6 stool and vaginal swabs will be collected per women if they attend as expected. Fetal growth will be measured by 5-6 weekly ultrasound scans.
The sample set will be repeated if the woman has fever during pregnancy or post-partum (estimated at 5% of the women).
POTENTIAL VALUE Identifying biochemical markers that are associated with preterm can guide in designing the most effective targeted intervention strategies aimed at women at risk for preterm birth.
Funder & grant reference number: Sidra Medical and Research Center (Sidra)/ B9R01250; and supported by Wellcome [220211; assigned to Nicholas Day];
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Characterization of the molecular signature of 30 preterm pregnancies defined by real-time PCR | up to 6 weeks post-partum |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of women who completed two weekly sampling | up to delivery | |
| Proportion of rate of drop-out from sampling | up to delivery | |
| Pain scores of the different samples from pregnant women. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
The participant will not enter the study or continue in the study if ANY of the following apply:
Not provided
Not provided
Target population: First trimester pregnant women with a viable pregnancy who will be followed for the outcome of interest of preterm births on the Thailand-Myanmar border
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shoklo Malaria Research Unit | Mae Sot | Changwat Tak | 63110 | Thailand |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41087373 | Derived | Ahmad F, Lakshmanan AP, Alabduljabbar S, Ahmed SH, Ahmed A, Kabeer BSA, Marr AK, Kino T, Brummaier T, McGready R, Nosten F, Chaussabel D, Al Khodor S, Terranegra A. Placental and cord blood DNA methylation in preterm birth: exploring the epigenetic role of maternal dietary protein. NPJ Sci Food. 2025 Oct 14;9(1):206. doi: 10.1038/s41538-025-00566-w. | |
| 33040018 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Blood sample, vaginal swab and stool specimen will be collected.
| up to 6 weeks post-partum |
| Molecular signature in relation to infection during pregnancy defined by real-time PCR | up to delivery |
| Molecular signature across the duration of pregnancy and post-partum time defined by real-time PCR | From enrolment at 8-14 weeks of pregnancy to 4-6 weeks post-partum |
| Brummaier T, Syed Ahamed Kabeer B, Wilaisrisak P, Pimanpanarak M, Win AK, Pukrittayakamee S, Marr AK, Kino T, Al Khodor S, Terranegra A, Carrara VI, Nosten F, Utzinger J, Chaussabel D, Paris DH, McGready R. Cohort profile: molecular signature in pregnancy (MSP): longitudinal high-frequency sampling to characterise cross-omic trajectories in pregnancy in a resource-constrained setting. BMJ Open. 2020 Oct 10;10(10):e041631. doi: 10.1136/bmjopen-2020-041631. |
| 30782707 | Derived | Brummaier T, Syed Ahamed Kabeer B, Lindow S, Konje JC, Pukrittayaamee S, Utzinger J, Toufiq M, Antoniou A, Marr AK, Suriyakan S, Kino T, Al Khodor S, Terranegra A, Nosten F, Paris DH, McGready R, Chaussabel D. A prospective cohort for the investigation of alteration in temporal transcriptional and microbiome trajectories preceding preterm birth: a study protocol. BMJ Open. 2019 Jan 15;9(1):e023417. doi: 10.1136/bmjopen-2018-023417. |